IUHSA
SUPN icon

Itau Unibanco Holding S.A.’s Supernus Pharmaceuticals SUPN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,894
Closed -$69K – 828
2019
Q4 		$69K Buy
+2,894
New +$70.3K ﹤0.01% 625
2018
Q4 		– Sell
-2,251
Closed -$113K – 670
2018
Q3 		$113K Buy
+2,251
New +$111K 0.01% 453

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Itau Unibanco Holding S.A.'s SUPN Position: Q1 2020 in Review

Itau Unibanco Holding S.A. sold out of Supernus Pharmaceuticals (SUPN) in Q1 2020, closing a stake of 2,894 shares — an estimated $69K sold.

Itau Unibanco Holding S.A. first reported a position in SUPN in Q3 2018 and held it in 2 quarters. The position peaked at $113K in Q3 2018. 208 funds tracked by Wall St. Rank hold SUPN as of Q1 2020.

  • Itau Unibanco Holding S.A. reported no remaining Supernus Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 2,894 Supernus Pharmaceuticals shares in Q1 2020, an estimated $69K.
  • Itau Unibanco Holding S.A. first reported a position in Supernus Pharmaceuticals in Q3 2018 and held it in 2 quarters.
  • Itau Unibanco Holding S.A.'s Supernus Pharmaceuticals position peaked at $113K in Q3 2018.
  • 208 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2020.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2020, filed 15 May 2020.